Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Evropská unie - chorvatština - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - вилдаглиптин, metformin hidroklorid - dijabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 i 5. 1 za dostupne podatke o različitim kombinacijama).

Zomarist Evropská unie - chorvatština - EMA (European Medicines Agency)

zomarist

novartis europharm limited  - вилдаглиптин, metformin hidroklorid - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

Eucreas Evropská unie - chorvatština - EMA (European Medicines Agency)

eucreas

novartis europharm limited - вилдаглиптин, metformin hidroklorid - dijabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Xalatan 50 mikrograma/ml kapi za oko, otopina Chorvatsko - chorvatština - HALMED (Agencija za lijekove i medicinske proizvode)

xalatan 50 mikrograma/ml kapi za oko, otopina

upjohn eesv, rivium westlaan 142, capelle aan den ijssel, nizozemska - latanoprost - kapi za oko, otopina - 50 mikrograma/ml - urbroj: 1 ml otopine sadrži 50 mikrograma latanoprosta

Relpax 20 mg filmom obložene tablete Chorvatsko - chorvatština - HALMED (Agencija za lijekove i medicinske proizvode)

relpax 20 mg filmom obložene tablete

upjohn eesv, rivium westlaan 142, capelle aan den ijssel, nizozemska - eletriptanbromid - filmom obložena tableta - 20 mg - urbroj: jedna filmom obložena tableta sadrži 20 mg eletriptana (u obliku eletriptanbromida)

Relpax 40 mg filmom obložene tablete Chorvatsko - chorvatština - HALMED (Agencija za lijekove i medicinske proizvode)

relpax 40 mg filmom obložene tablete

upjohn eesv, rivium westlaan 142, capelle aan den ijssel, nizozemska - eletriptanbromid - filmom obložena tableta - 40 mg - urbroj: jedna filmom obložena tableta sadrži 40 mg eletriptana (u obliku eletriptanbromida)

Entresto Evropská unie - chorvatština - EMA (European Medicines Agency)

entresto

novartis europharm limited - sacubitril, валсартан - zastoj srca - antagonisti angiotenzina ii, druge kombinacije, agenti koji djeluju na ренин-ангиотензиновую sustav - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.

Neparvis Evropská unie - chorvatština - EMA (European Medicines Agency)

neparvis

novartis europharm limited - sacubitril, валсартан - zastoj srca - sredstva koja djeluju na sustav renin-angiotenzina - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.